Glypican-3 targeting compositions and uses thereof

TW202637574APending Publication Date: 2026-09-16PEPTIDREAM INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148455
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-11
Filing Date
2025-12-10
Publication Date
2026-09-16

Smart Images

  • Figure 00000653_0000
    Figure 00000653_0000
  • Figure 00000655_0000
    Figure 00000655_0000
  • Figure 00000657_0000
    Figure 00000657_0000
Patent Text Reader

Abstract

Provided herein are GPC-3 binding peptides and non-radionuclide conjugates thereof, and compositions comprising the same. The GPC-3 targeting peptides and non-radionuclide conjugates thereof have avidity to GPC3. The GPC-3 targeting peptides described herein can optionally further comprise a linker connecting the GPC-3 targeting peptide to a non-radionuclide moiety. The non-radionuclide conjugates described herein comprises the GPC-3 targeting peptide linked to a non-radionuclide moiety, either directly or through a linker. Further provided herein are methods of diagnosing and / or treating a disease or condition characterized by GPC-3 expression (e.g., overexpression), such as various cancers, by administering the described peptides and non-radionuclide conjugates thereof, or compositions thereof.
Need to check novelty before this filing date? Find Prior Art